Get started
Author

Laëtitia Penso

Association Between Adult Acne and Dietary Behaviors: Findings From the NutriNet-Santé Prospective Cohort Study
2020 · Laetitia Penso, Mathilde Touvier, et al. · JAMA Dermatology · 125
PDF
Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients
2021 · Laura Semenzato, Jérémie Botton, et al. · Hypertension · 118
Association Between Biologics Use and Risk of Serious Infection in Patients With Psoriasis
2021 · Laetitia Penso, Rosemary Dray-Spira, et al. · JAMA Dermatology · 106
PDF
Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database
2022 · Laura Pina Vegas, Laetitia Penso, et al. · JAMA Dermatology · 72
Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
2021 · Laura Pina Vegas, Philippe Le Corvoisier, et al. · Rheumatology · 68
PDF
Epidemiologic study of patients with psoriatic arthritis in a real-world analysis: a cohort study of the French health insurance database
2020 · Laura Pina Vegas, Emilie Sbidian, et al. · Rheumatology · 51
Risk of Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis/Ankylosing Spondylitis Initiating Interleukin‐17 Inhibitors: A Nationwide Population‐Based Study Using the French National Health Data System
2021 · Laetitia Penso, Christina Bergqvist, et al. · Arthritis & Rheumatology · 46
Trends in mortality rates for Stevens–Johnson syndrome and toxic epidermal necrolysis: experience of a single centre in France between 1997 and 2017
2019 · T. Bettuzzi, L. Penso, et al. · British Journal of Dermatology · 41
Meta‐analysis results do not reflect the real safety of biologics in psoriasis*
2020 · S. Afach, A. Chaimani, et al. · British Journal of Dermatology · 36
Psoriasis-related treatment exposure and hospitalization or in-hospital mortality due to COVID-19 during the first and second wave of the pandemic: cohort study of 1 326 312 patients in France
2021 · L. Penso, R. Dray-Spira, et al. · British Journal of Dermatology · 15
Influence of sex on the persistence of different classes of targeted therapies for psoriatic arthritis: a cohort study of 14 778 patients from the French health insurance database (SNDS)
2023 · Laura Pina Vegas, Laetitia Penso, et al. · RMD Open · 14
PDF
Drop in biological initiation for patients with psoriasis during the COVID‐19 pandemic
2021 · L. Penso, R. Dray‐Spira, et al. · British Journal of Dermatology · 12
PDF
French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025
2025 · Marie Masson Regnault, Emilie Brenaut, et al. · Journal of the European Academy of Dermatology and Venereology · 11
PDF
Comment on ‘Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19‘ by Konig et al. Long-term exposure to hydroxychloroquine or chloroquine and the risk of hospitalisation with COVID-19: a nationwide, observational cohort study in 54 873 exposed individuals and 155 689 matched unexposed individuals in France
2020 · Emilie Sbidian, Laetitia Penso, et al. · Annals of the Rheumatic Diseases · 10
PDF
Nicotine-replacement therapy, as a surrogate of smoking, and the risk of hospitalization with Covid-19 and all-cause mortality: a nationwide, observational cohort study in France
2020 · Mahmoud Zureik, Bérangère Baricault, et al. · medRxiv · 10
PDF
Risk of serious infection associated with different classes of targeted therapies used in psoriatic arthritis: a nationwide cohort study from the French Health Insurance Database (SNDS)
2024 · Léa Bastard, Pascal Claudepierre, et al. · RMD Open · 9
PDF
Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts
2021 · Morgane Condamina, Laetitia Penso, et al. · Dermatology · 9
Ultraprocessed Food Intake and Psoriasis
2024 · Laetitia Penso, Mathilde Touvier, et al. · JAMA Dermatology · 8
Persistence of second-line biologics in psoriasis after first-line biologic failure: a nationwide cohort study from the French health insurance database (SNDS)
2023 · Clarisse Marcombes, Laetitia Penso, et al. · British Journal of Dermatology · 7
First-Line Persistence of Biologics in Psoriasis from a Cohort Based on French Medico-Administrative Data
2023 · Clarisse Marcombes, Laetitia Penso, et al. · Journal of Investigative Dermatology · 4
PDF
Antibiotic Use and the Persistence of Biologic Therapies in Patients With Psoriasis
2025 · Raphaël Ouakrat, Laetitia Penso, et al. · JAMA Dermatology · 3
Serious adverse events associated with systemic treatments for psoriasis: a network meta-analysis of observational studies and randomized controlled trials
2024 · Robin Guelimi, Anna Chaimani, et al. · Cochrane Database of Systematic Reviews · 3
PDF
Pos0201 Risk of Major Adverse Cardiovascular Events in Patients Initiating Biologics/apremilast for Psoriatic Arthritis: a Nationwide Population-based Study Using the French Health Insurance Database
2021 · L. Pina Vegas, P. Le Corvoisier, et al. · Annals of the Rheumatic Diseases · 2
PDF
Pos0075 Long-term Persistence of First-line Biologics for Psoriatic Arthritis and Psoriasis: a Cohort Study of 23,423 Patients From the French Health Insurance Database (snds)
2022 · L. Pina Vegas, L. Penso, et al. · Annals of the Rheumatic Diseases · 1
PDF
Risque de maladie inflammatoire chronique des intestins chez les patients atteints de psoriasis, de rhumatisme psoriasique ou de spondylarthrite ankylosante et initiant un traitement par anti-interleukine 17
2021 · L. Penso, C. Bergqvist, et al. · Revue du Rhumatisme · 1
Works count: 53
Citation count: 783
H-index: 12
I10-index: 15
Year
Topic
Type